A new gene therapy turns glial cells—abundant support cells in the brain—into neurons, repairing damage that results from stroke and significantly improving motor function in mice.
A paper describing the new therapy, which uses the NeuroD1 gene, appears online in the journal Molecular Therapy. Once further developed, this NeuroD1-based gene therapy could potentially be used to treat stroke, which is a leading cause of disability in the U.S., with 800,000 new stroke patients every year.
“The current treatment for stroke has a narrow time window, typically within a few hours after the occurrence of stroke,” said lead author Yuchen Chen, a postdoctoral fellow at Penn State. “Many patients cannot receive the treatment in time and as a result, often suffer from permanent disability caused by irreversible neuronal loss. There is an urgent need to develop a new therapy to regenerate new neurons and restore lost brain functions among stroke patients.”
The human brain has approximately 86 billion neurons. While mini-strokes can be tolerated, moderate stroke involving the loss of billions of neurons leaves detrimental effects that do not spontaneously recover.
“So, the critical question that is still unanswered in the neuroregeneration field is how can we regenerate billions of new neurons in a patient’s brain after stroke?” said Gong Chen, professor of biology and Verne M. Willaman Chair in Life Sciences at Penn State and leader of the research team. “The biggest obstacle for brain repair is that neurons cannot regenerate themselves. Many clinical trials for stroke have failed over the past several decades, largely because none of them can regenerate enough new neurons to replenish the lost neurons.”
Gong Chen and his team pioneered a new approach to regenerate functional neurons using glial cells, a group of cells surrounding every single neuron in the brain that provide essential support to neurons. Unlike neurons, glial cells can divide and regenerate themselves, especially after brain injury.
“I believe that turning glial cells that are already present in the brain into new neurons is the best way to replenish the lost neurons,” said Gong Chen. “These glial cells are the neighbors of the dead neurons in the brain and are likely to share the same ancestral cellular lineage.”
Gong Chen’s team previously reported that a single genetic neural factor, NeuroD1, could directly convert glial cells into functional neurons inside mouse brains with Alzheimer’s disease, but the total number of neurons generated was limited. The research team believed that this limited regeneration was due to the retroviral system used to deliver NeuroD1 to the brain. In the current study, the research team used the AAV viral system, which is now the first choice for gene therapy in the nervous system, to deliver NeuroD1 into mouse motor cortex that had suffered from stroke.
Many neurons die after stroke but surviving glial cells can proliferate and form a glial scar in the stroke areas. The AAV system was designed to express NeuroD1 preferentially in the glial cells that form these scars, turning them directly into neuronal cells. Such direct glia-to-neuron conversion technology not only increased neuronal density in the stroke areas, but also significantly reduced brain tissue loss caused by the stroke.
Interestingly, the newly converted neurons showed similar neuronal properties to the neurons that were lost after stroke. This suggests a potential impact of the local glial lineage on the converted neuronal identity.
“The most exciting finding of this study is to see the newly converted neurons being fully functional in firing repetitive action potentials and forming synaptic networks with other preexisting neurons,” said Gong Chen. “They also send out long-range axonal projections to the right targets and facilitate motor functional recovery.”
A separate collaborative work led by Gregory Quirk, professor at the University of Puerto Rico, further tested the NeuroD1-based gene therapy in a rat stroke model. Quirk and colleagues also found that this direct glia-to-neuron conversion technology can rescue cognitive functional deficits induced by stroke.
“Because glial cells are everywhere in the brain and can divide to regenerate themselves, our study provides the proof-of-concept that glial cells in the brain can be tapped as a fountain of youth to regenerate functional new neurons for brain repair not only for stroke but also for many other neurological disorders that result in neuronal loss,” said Yuchen Chen. “Our next step is to further test this technology and ultimately to translate it into clinically effective therapies to benefit millions of patients worldwide.”
Learn more: Gene therapy helps functional recovery after stroke
The Latest on: Functional recovery after stroke
[google_news title=”” keyword=”functional recovery after stroke” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Functional recovery after stroke
- Quick action on the golf course resulted in rapid recovery from strokeon April 30, 2024 at 12:12 pm
George Richards had just hit his tee shot on the sixth hole. He was playing a nine-hole round with the same golfing buddies he met up with every Thursday afternoon ...
- Revolutionizing Spinal Injury Treatment: Common Drug Found To Prevent Damage to Fat Tissueon April 27, 2024 at 10:17 pm
Study in mice finds that a widely-used medication prevents damage to fat tissue from injuries A new animal study suggests that conditions like diabetes, heart attacks, and vascular diseases, commonly ...
- Post-Stroke Depression (PSD): Identifying Signs And Symptoms of Mood Disorder After a Strokeon April 25, 2024 at 10:12 pm
Post-stroke depression (PSD) is a mood disorder that occurs after a person experiences a stroke. It's characterised by feelings of sadness, hopelessness and loss of interest in activities that were ...
- Neurons Disrupt Metabolism Following Spinal Cord Injuryon April 25, 2024 at 9:40 pm
Researchers discovered in mice that conditions such as diabetes diagnosed in people with spinal cord injuries, can be linked to abnormal post-injury neuronal activity.
- Stroke Recovery: A Timelineon April 24, 2024 at 9:00 pm
How much progress a person can make and the timeline for their recovery depend on the type and location of the stroke and the patient’s age and overall health, says Richard Harvey, M.D., clinical ...
- After spinal cord injury, neurons wreak havoc on metabolism: Study finds common drug may prevent some of the effectson April 24, 2024 at 10:14 am
Conditions such as diabetes, heart attack, and vascular diseases commonly diagnosed in people with spinal cord injuries can be traced to abnormal post-injury neuronal activity that causes abdominal ...
- After spinal cord injury, neurons wreak havoc on metabolismon April 23, 2024 at 5:00 pm
Conditions such as diabetes, heart attack and vascular diseases commonly diagnosed in people with spinal cord injuries can be traced to abnormal post-injury neuronal activity that causes abdominal fat ...
- Researchers call for enhanced research into common post-stroke conditionon April 23, 2024 at 10:33 am
Lateropulsion, a clinical condition that results in the body leaning to one side, affects about half of all stroke survivors.
- The hidden struggle of lateropulsion in stroke survivorson April 23, 2024 at 3:09 am
Lateropulsion, a clinical condition which results in the body leaning to one side, affects about half of all stroke survivors.
- Optimizing differentiation protocols and experimental assays to study patient-specific astrocyteson April 16, 2024 at 10:05 am
In a joint effort with RIKEN BioResource Research Center and Mitsubishi Tanabe Pharma Corporation, a team of researchers led by Dr. Haruhisa Inoue (Professor, Department of Cell Growth and ...
via Bing News